Effect of partial compliance on cardiovascular medication effectiveness
Open accessAbstract
The typical assessment of mediation compliance by physicians is similar to the assessment of an iceberg from the ship captain's window. The difference is that when a captain sees ice in the water, he assumes that what he sees might be only the “tip of the iceberg” requiring attention. In contrast, patients who inadvertently omit many doses and doctors who attribute poor control to lack of drug efficacy may have no concept that the underlying problem is poor compliance with the prescribed regimen. If the captain fails to recognise an iceberg in advance, he knows that he must turn his immense vessel rapidly to avoid disaster. Failing to recognise inadequate compliance as the source of the patient's problem, the physician is unaware of the appropriate action to be taken. Instead, the physician typically prescribes even more medication as a higher dose, or an alternative or second drug. Unfortunately, the patient often remains on a potentially fatal collision course. Why is this scenario so common in medical practice? Inherent in the answers to these questions is a message for every clinician who prescribes medications: Look under the surface. Don't assume that you know which patients take their medication regularly. Don't assume that failure to control hypertension, hyperlipidaemia or other measures of cardiovascular disease is caused by lack of efficacy of the prescribed medications. In daily practice, after the physician determines the diagnosis and selects an appropriate treatment, the burden of achieving a good outcome is shifted to the patient. Depending on the setting, patients might be left to accomplish this important task of self management with little guidance. Both physicians and patients need to understand that key factors affecting outcome are “compliance” (that is, attempting to take the medication each day as prescribed) and “persistence” (that is, continuing to take the …
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Suboptimal compliance in randomized trials is well known to cause negative results.
“Suboptimal compliance in randomized trials is well known to cause negative results(97–101).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A systematic review of the associations between dose regimens and medication compliance
Claxton, A. J., Cramer, J., & Pierce, C. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80109-0 · Cited by 2,388 · see citing works
Self-citationHow often is medication taken as prescribed? A novel assessment technique
Cramer, J. A. (1989) · JAMA · doi:10.1001/jama.261.22.3273 · Cited by 1,032 · see citing works
Self-citationLipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
Manninen, V. (1988) · JAMA · doi:10.1001/jama.1988.03410050061031 · Cited by 954 · see citing works
The Coronary Drug Project Research Group (1980) · New England Journal of Medicine · doi:10.1056/nejm198010303031804 · Cited by 659 · see citing works
Persistence of Use of Lipid-Lowering Medications
Avorn, J., Monette, J., Lacour, A. S., Bohn, R. L., Monane, M., Mogun, H., & LeLorier, J. (1998) · JAMA · doi:10.1001/jama.279.18.1458 · Cited by 635 · see citing works
The Multilevel Compliance Challenge: Recommendations for a Call to Action
Miller, N. H., Hill, M. N., Kottke, T. E., & Ockene, I. S. (1997) · Circulation · doi:10.1161/01.cir.95.4.1085 · Cited by 493 · see citing works
Patient Compliance in Medical Practice and Clinical Trials
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-7-582_3 · Cited by 463 · see citing works
Compliance Declines Between Clinic Visits
Cramer, J. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390190143023 · Cited by 384 · see citing works
Self-citationPsaty, B. M. (1990) · JAMA · doi:10.1001/jama.263.12.1653 · Cited by 268 · see citing works
Burnier, M., Schneider, M. P., Chioléro, A., Stubi, C.-L. F., & Brunner, H. R. (2001) · Journal of Hypertension · doi:10.1097/00004872-200102000-00022 · Cited by 262 · see citing works
Monane, M., Bohn, R. L., Gurwitz, J. H., Glynn, R., Levin, R., & Avorn, J. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.12.1805 · Cited by 253 · see citing works
Microelectronic Systems for Monitoring and Enhancing Patient Compliance With Medication Regimens
Cramer, J. A. (1995) · Drugs · doi:10.2165/00003495-199549030-00001 · Cited by 174 · see citing works
Self-citationEnhancing Patient Compliance in the Elderly
Cramer, J. A. (1998) · Drugs & Aging · doi:10.2165/00002512-199812010-00002 · Cited by 128 · see citing works
Self-citationEnhancing Medication Compliance for People with Serious Mental Illness
Cramer, J. A., & Rosenheck, R. (1999) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199901000-00009 · Cited by 128 · see citing works
Self-citationUnderutilization of Antihypertensive Drugs and Associated Hospitalization
Maronde, R. F., Chan, L. S., Larsen, F. J., Strandberg, L. R., Laventurier, M. F., & Sullivan, S. R. (1989) · Medical Care · doi:10.1097/00005650-198912000-00007 · Cited by 104 · see citing works
Cramer, J. A. (1998) · PubMed · Cited by 78 · see citing works
Self-citationHow to Improve Adherence with Prescribed Treatment in Hypertensive Patients?
Waeber, B., Burnier, M., & Brunner, H. R. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200035063-00006 · Cited by 66 · see citing works
Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.
Rangno, R., & Langlois, S. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb01939.x · Cited by 58 · see citing works
A STUDY DESIGN FOR COMPARING THE EFFECTS OF MISSING DAILY DOSES OF ANTIHYPERTENSIVE DRUGS
Johnson, B. F., & Whelton, A. (1994) · American Journal of Therapeutics · doi:10.1097/00045391-199412000-00003 · Cited by 40 · see citing works
Compliance with Antihypertensive Therapy
Rudd, P. (1994) · Cardiology in Review · doi:10.1097/00045415-199409000-00002 · Cited by 19 · see citing works
Depth-Psychological Under-standing: The Methodologic Grounding of Clinical Interpretations.
Nowak, J. (1999) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199908000-00014 · Cited by 13 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Claxton AJ, Cramer JA, Pierce C. Medication compliance: the importance of the dosing regimen. Clin Therapeutics 2001;23:1296-310. c Overview of 76 studies with electronic compliance monitoring describes dose taking and dose timing deficits across a wide variety of medical disorders.
Cited by
Sorted by citations
A systematic review and economic evaluation of statins for the prevention of coronary events
Ward, S., Lloyd Jones, M., Pandor, A., Holmes, M., Ara, R., Ryan, A., Yeo, W., & Payne, N. (2007) · Health Technology Assessment · doi:10.3310/hta11140 · Cited by 556 · see citing works
Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253 · see citing works
Vitamin K to prevent fractures in older women: systematic review and economic evaluation
Stevenson, M., Lloyd-Jones, M., & Papaioannou, D. (2009) · Health Technology Assessment · doi:10.3310/hta13450 · Cited by 90 · see citing works
Granger, A. L., Fehnel, S. E., Hogue, S. L., Bennett, L., & Edin, H. M. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.08.018 · Cited by 35 · see citing works
- Authors
- Cramer, J. A.
- Affiliations
- Yale University (US)
- Corresponding author
- Cramer, Joyce A
- ORCID
- Cramer, Joyce A
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2002-08
- Volume
- 88
- Issue
- 2
- Pages
- 203-206
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- PMC
- PMC1767238
- OpenAlex
- W2139727491
- Cited by
- 57
- References
- 21
- Citations by year
- 2023: 1 · 2021: 2 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 1 · 2012: 5
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Heart (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- medication adherence, treatment persistence, cardiovascular drugs, hypertension control, hyperlipidemia, self-management, physician prescribing
- MeSH terms
- Cardiovascular Agents, Humans, Microcomputers, Patient Compliance, Treatment Outcome, Drug Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
